Michael Mullan, M.B.B.S., Ph.D., has served as the Chief Executive Officer and Chief Scientific Officer for Archer Pharmaceuticals since its inception in 2008. Dr. Mullan has previously served as CEO or CSO of both publicly traded and private drug development companies including The Roskamp Institute which he co-founded in 2003.
In the world of drug discovery, there is a place that haunts everybody - from basic researchers to needing patients - known as the "Valley of Deathâ. The Valley of Death is where the vast majority of new therapeutic ideas go to die.